IFNG and asthma: Indeed, small, independent clinical studies in patients with steroid-resistant asthma revealed that recurrent systemic administration of rIFN-γ improved lung function and reduced the severity of asthma outcomes.85,86 Thus, our findings suggest that IFN-γ (and the pathways it triggers) could represent a rational, promising approach to mitigating neutrophilic asthma.